Visiongain Publishes Infectious Disease Diagnostics Market Report 2022-2032
The global Infectious Disease Diagnostics market was valued at US$ 28,272.2 million in 2021 and is projected to grow at a CAGR of 6.61% during the forecast period 2022-2032.
Visiongain Publishes Monoclonal Antibody Discovery and Analysis Market Report 2022-2032
The global Monoclonal Antibody Discovery and Analysis market was valued at US$5,234 million in 2021 and is projected to grow at a CAGR of 9.0% during the forecast period 2022-2032.
Visiongain Publishes Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2022-2032
The global CMO of Sterile Injectable Drugs market was valued at US$19,090.4 million in 2021 and is projected to grow at a CAGR of 9.10% during the forecast period 2022-2032.
Neurostimulation Devices Market Report 2023-2033
The global Neurostimulation Devices market is valued at US$8,127.3 million in 2022 and is projected to grow at a CAGR of 11.35% during the forecast period 2023-2033.
Visiongain Publishes Virtual Power Plant (VPP) Market Report 2023-2033
The global Virtual Power Plant (VPP) market was valued at US$448.1 million in 2022 and is projected to grow at a CAGR of 17.8% during the forecast period 2023-2033.
Visiongain Publishes Water Desalination Market Report 2022-2032
The global Water Desalination market was valued at US$17.1 billion in 2021 and is projected to grow at a CAGR of 10.2% during the forecast period 2022-2032.
Visiongain Publishes Cardiovascular Devices Market Report 2023-2033
The global Cardiovascular Devices market is estimated to be valued at US$59.57 billion in 2022 and is projected to grow at a CAGR of 6.92% during the forecast period 2023-2033.
Visiongain Publishes Respiratory Inhalers Market Report 2023-2033
The respiratory inhalers market is valued at US$42.93 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period 2023-2033.
Visiongain Publishes Unmanned Helicopters Market Report 2023-2033
The global Unmanned Helicopters market was valued at US$6,087 million in 2022 and is projected to grow at a CAGR of 12.0% during the forecast period 2023-2033.
Visiongain Publishes Protein Expression, Purification and Isolation Technology Market Report 2022-2032
The Global Protein Expression, Purification and Isolation Technology market was valued at US$9,305.7 million in 2021 and is projected to grow at a CAGR of 9.79% during the forecast period 2022-2032.
Visiongain Publishes Alzheimer’s Therapeutics Market Report 2022-2032
The Alzheimer’s Therapeutics market is valued at US$2,870.25 million in 2022 and is projected to grow at a CAGR of 9.17% during the forecast period 2022-2032.
Visiongain Publishes Military Electro-Optical and Infrared (EO/IR) Systems Market Report 2022-2032
The global Military Electro-Optical and Infrared (EO/IR) Systems market was valued at more than US$8.00 billion in 2022 and is projected to grow at a CAGR of 16.4% during the forecast period 2022-2032.
Visiongain Publishes Gene Amplification Technologies Market Report 2023-2033
The Gene Amplification Technologies market was valued at US$4,587 million in 2022 and is projected to grow at a CAGR of 9.8% during the forecast period 2023-2033.
Visiongain Publishes Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Report 2023-2033
The CBRN Defence market was valued at US$ 17.8 billion in 2022 and is projected to grow at a CAGR of 6.0% during the forecast period 2023-2033.
Visiongain Publishes Stem Cell Technologies and Applications Market Report 2022-2032
The global stem cell technologies and applications market was valued at US$9,247 million in 2021 and is projected to grow at a CAGR of 8.9% during the forecast period 2022-2032.
Visiongain Publishes Biosimilars and Follow-On Biologics Market Report 2023-2033
The biosimilars and follow-on biologics market is valued at US$19,668.3 million in 2022 and is projected to grow at a CAGR of 31.14% during the forecast period 2023-2033.
Visiongain Publishes Medical Imaging Market Report 2022-2032
The Medical Imaging market was valued at US$38.6 billion in 2021 and is projected to grow at a CAGR of 5.46% during the forecast period 2022-2032.
Visiongain Publishes Military Simulation, Modelling and Virtual Training Market Report 2023-2033
The global military simulation modelling and virtual training market was valued at US$16,087 million in 2022 and is projected to grow at a CAGR of 8.2% during the forecast period 2023-2033.
Visiongain Publishes Antibody Drug Conjugates Market Report 2022-2032
The global antibody drug conjugates market was valued at US$3,668 million in 2021 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.
Visiongain Publishes Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2022-2032
The Macular Degeneration (AMD) and Other Retinal Diseases Drugs market was valued at US$25.29 billion in 2021 and is projected to grow at a CAGR of 7.87% during the forecast period 2022-2032.
